Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Volgogradenergosbyt reported for 9 months of 2024 by RAS

10/28/24 VGSB

VTB reported for 9 months of 2024 by IFRS

10/28/24 VTBR

Yakutskenergo reported for 9 months of 2024 by RAS

10/28/24 YKEN

Demand for Delimobile's services grew by 24% in 9 months

10/28/24 DELI

Alrosa to invest ₽2.8 billion in Vilyuysk power plant

10/28/24 ALRS

International Trade Center reported for 9 months of 2024 by RAS

10/25/24 WTCM

Moscow Exchange add 10 more shares to OTC trading

10/25/24 MOEX

Samolet's sales for 9 months increased by 25%

10/25/24 SMLT

Rosseti Moscow Region reported for 9 months of 2024 by RAS

10/25/24 MSRS

Board of Directors of Henderson recommended that dividends be paid for 9 months 2024

10/25/24 HNFG